Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | FHIT | P49789 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 3/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9267958 | 0.84 | TSHR (0.49) | ALDH1A1KMT2AMEN1KDM4ELMNA | |
| SCHEMBL12243908 | 0.81 | KMT2A (0.39) | ALDH1A1MAPTKMT2AMEN1POLB | |
| SCHEMBL12220426 | 0.80 | ALDH1A1 (0.39) | ALDH1A1MAPTKMT2AMEN1POLB | |
| SCHEMBL502220 | 0.79 | MAPT (0.38) | ALDH1A1MAPTKMT2AMEN1POLB | |
| SCHEMBL9626894 | 0.74 | TSHR (0.48) | ALDH1A1MAPTKMT2AMEN1KDM4E | |
| SCHEMBL8081015 | 0.71 | SMN1; SMN2 (0.44) | ALDH1A1KMT2AKDM4ELMNAL3MBTL1 | |
| SCHEMBL3172992 | 0.70 | KMT2A (0.35) | ALDH1A1MAPTKMT2AMEN1POLB | |
| SCHEMBL22468788 | 0.68 | HSD17B3 (0.42) | ALDH1A1MAPTKMT2AMEN1HTT | |
| SCHEMBL6022461 | 0.67 | — | — | |
| SCHEMBL8909319 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110914240-B | Norbornenone compounds releasing carbon monoxide | 奥塔哥创新有限公司 | 2024-02-20 | — | — | CN | disclosed |
| EP-2558538-A2 | HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS | Oligasis (US) | 2013-02-20 | — | — | EP | disclosed |
| EP-2512462-A1 | MULTIFUNCTIONAL ZWITTERIONIC POLYMER CONJUGATES | Oligasis (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011130694-A2 | HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS | OLIGASIS (US) | 2011-10-20 | — | — | WO | disclosed |
| EP-1270642-B1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KIRIN CO LTD (JP) | 2011-08-31 | — | — | EP | disclosed |
| WO-2011075736-A1 | MULTIFUNCTIONAL ZWITTERIONIC POLYMER CONJUGATES | OLIGASIS (US) | 2011-06-23 | — | — | WO | disclosed |
| EP-1400550-B1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KIRIN CO LTD (JP) | 2010-06-23 | — | — | EP | disclosed |
| US-7691367-B2 | Branched polyalkylene glycols | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-04-06 | — | — | US | disclosed |
| US-7547765-B2 | Branched polyalkylene glycols | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2009-06-16 | — | — | US | disclosed |
| US-20080125350-A1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-05-29 | — | — | US | disclosed |
| EP-1313750-A1 | METHOD FOR PRODUCING WATER-SOLUBLE SACCHARIDE CONJUGATES AND SACCHARIDE MIMETICS BY DIELS-ALDER REACTION | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2003-05-28 | — | — | EP | disclosed |
| EP-1270642-A1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-01-02 | — | — | EP | disclosed |
| WO-2002016378-A1 | METHOD FOR PRODUCING WATER-SOLUBLE SACCHARIDE CONJUGATES AND SACCHARIDE MIMETICS BY DIELS-ALDER REACTION | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2002-02-28 | — | — | WO | disclosed |
| EP-0726275-B1 | Benzodiazepine protein conjugates and their use in benzodiazepine immunoassays | BOEHRINGER MANNHEIM GMBH (DE) | 1999-01-27 | — | — | EP | disclosed |
| EP-0618192-B1 | Homobidental, trifunctional maleimide linkers and their application in immunologically active conjugates | BOEHRINGER MANNHEIM GMBH (DE) | 1998-09-16 | — | — | EP | disclosed |
| US-5662911-A | USED AS IMMUNOGENS TO OBTAIN ANTIBODIES TO BENZODIAZEPINES | BOEHRINGER MANNHEIM GMBH (DE) | 1997-09-02 | — | — | US | disclosed |
| US-5606030-A | IMMUNOGENIC PROTEINS; USEFUL FOR INDUCING ANTI-PEPTIDE IMMUNE RESPONSES IN MAMMALS, HIV-NEUTRALIZING ANTIBODIES IN MAMMALS AND FORMULATING VACCINES TO PREVENT HIV INFECTIONS | MERCK & CO., INC. (US) | 1997-02-25 | — | — | US | disclosed |
| EP-0726275-A1 | Benzodiazepine protein conjugates and their use in benzodiazepine immunoassays | Roche Diagnostics GmbH (DE) | 1996-08-14 | — | — | EP | disclosed |
| EP-0618192-A1 | Homobidental, trifunctional mazeimide linkers and their application in immunologically active conjugates | Roche Diagnostics GmbH (DE) | 1994-10-05 | — | — | EP | disclosed |
| EP-0467700-A2 | Coconjugate vaccines comprising immunogenic protein, HIV related peptides, and anionic moieties | MERCK & CO. INC. (US) | 1992-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125350-A1 | BRANCHED POLYALKYLENE GLYCOLS | LNPEP, ANPEP, ENPEP | ALDH1A1 2967/4885MAPT 4396/4885KMT2A 4612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.